Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Bünde – page 27

618 clinical trials in Bünde, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Bünde at a glance
618
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

618 trials in Bünde

Open in trial search

Arteriosclerosis

Not recruiting

Study on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Neurodermatitis

Not recruiting

Study on the Long-Term Safety and Effectiveness of Nemolizumab for Patients with Prurigo Nodularis

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Nemolizumab
  • Sponsor:Galderma S.A.

Cardiac amyloidosis

Not recruiting

Study of Vutrisiran for Patients with Transthyretin Amyloidosis and Heart Disease

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Vutrisiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Multiple sclerosis+1

Not recruiting

Study on the Effectiveness and Safety of Ocrelizumab for Patients with Progressive Multiple Sclerosis

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Methylprednisolone
  • Sponsor:F. Hoffmann-La Roche AG

Dyslipidaemia

Not recruiting

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Study on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer's Dementia Patients

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Quinidine Sulfate
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Schizophrenia

Not recruiting

Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Iclepertin
  • Sponsor:Boehringer Ingelheim International GmbH

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Asthma

Not recruiting

Study on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atuliflapon
  • Sponsor:AstraZeneca AB

Migraine+3

Not recruiting

Study Comparing Atogepant and Topiramate for Preventive Treatment in Adults with Migraine

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Systemic scleroderma

Not recruiting

Study of anifrolumab effectiveness compared to placebo in adults aged 18-70 with systemic sclerosis

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anifrolumab
  • Sponsor:AstraZeneca AB

Asthma

Not recruiting

Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:Chiesi Farmaceutici S.p.A.

Other cities in Germany

The busiest research cities in the country

All 505 cities in Germany

Clinical research in Bünde

What the registry says about research in the country

01 Nutritional and Metabolic Diseases

The clinical trial activity in Bünde is centered on Nutritional and Metabolic Diseases, with studies focused on improving care for obesity, overweight, and type 2 diabetes. These trials are mainly testing new treatment approaches and assessing how well they support weight management and blood sugar control.

  • Weight-related treatment studies in obesity and overweight
  • Type 2 diabetes research aimed at better glycaemic control
  • Trials exploring therapy effectiveness in people with combined metabolic conditions
  • Clinical research designed to improve everyday treatment options

Several studies also connect metabolic health with other conditions, showing a broad interest in practical treatment strategies for patients in routine care.

02 Kidney Disease Research

One important area of research in Bünde involves chronic kidney disease, with trials examining whether new treatment combinations can help preserve kidney function. The goal is to evaluate treatment effectiveness and support better long-term kidney health.

  • Chronic kidney disease as a key focus of ongoing research
  • Studies assessing kidney function outcomes
  • Testing new therapeutic combinations for improved disease control

This work reflects a strong interest in finding more effective options for people living with progressive kidney problems.

03 Obesity and Weight Management

Clinical trials in the area of obesity and overweight are exploring whether new therapies can support meaningful body weight reduction. These studies are aimed at evaluating treatment benefit in people who need better options for long-term weight control.

  • Obesity and overweight as main conditions under study
  • Research focused on weight change and treatment response
  • Testing new approaches for healthier metabolic outcomes

The trials address an important area of public health by looking for more effective ways to manage excess weight.

04 Metabolic Disease and Diabetes Care

Another major theme is type 2 diabetes management, where trials are comparing treatment approaches to see how well they maintain blood sugar levels in real-world practice. The emphasis is on improving treatment effectiveness for people who already use glucose-lowering medication.

  • Type 2 diabetes treatment optimization
  • Comparisons of longer-acting and daily insulin-based options
  • Focus on sustained blood sugar control over time

These studies may help shape more practical and patient-friendly diabetes care strategies.

05 Osteoarthritis and Joint Pain

Research also includes osteoarthritis, especially knee pain linked with obesity or overweight. The trials are looking at ways to ease joint symptoms while also supporting weight-related health goals.

  • Osteoarthritis with a focus on knee pain
  • Studies involving people with obesity or overweight
  • Evaluation of symptom relief and functional improvement

This area connects musculoskeletal care with metabolic health, reflecting the close relationship between body weight and joint discomfort.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.